IL87662A0 - Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides - Google Patents

Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides

Info

Publication number
IL87662A0
IL87662A0 IL87662A IL8766288A IL87662A0 IL 87662 A0 IL87662 A0 IL 87662A0 IL 87662 A IL87662 A IL 87662A IL 8766288 A IL8766288 A IL 8766288A IL 87662 A0 IL87662 A0 IL 87662A0
Authority
IL
Israel
Prior art keywords
alkoxy
thiobenzamides
benzamides
oct
azabi
Prior art date
Application number
IL87662A
Other languages
English (en)
Original Assignee
Naylor Robert John
Brenda Naylor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naylor Robert John, Brenda Naylor filed Critical Naylor Robert John
Publication of IL87662A0 publication Critical patent/IL87662A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL87662A 1987-09-04 1988-09-02 Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides IL87662A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878720805A GB8720805D0 (en) 1987-09-04 1987-09-04 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides

Publications (1)

Publication Number Publication Date
IL87662A0 true IL87662A0 (en) 1989-02-28

Family

ID=10623261

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87662A IL87662A0 (en) 1987-09-04 1988-09-02 Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides

Country Status (12)

Country Link
US (1) US4877794A (fr)
EP (1) EP0306345B1 (fr)
JP (1) JPH0269417A (fr)
AT (1) ATE88091T1 (fr)
AU (1) AU614768B2 (fr)
CA (1) CA1318595C (fr)
DE (1) DE3880240T2 (fr)
DK (1) DK492688A (fr)
GB (1) GB8720805D0 (fr)
IL (1) IL87662A0 (fr)
PH (1) PH25429A (fr)
ZA (1) ZA886586B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353372B1 (fr) * 1988-08-04 1993-02-03 Synthelabo S-N-(1-azabicyclo [2.2.2.]oct-3-yl)benzamides et thiobenzamides ayant une activité antischizophrénique
AU631632B2 (en) * 1989-04-21 1992-12-03 Novartis Ag Therapeutic use of 5-ht3 receptor antagonists
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
WO2002016357A2 (fr) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Composes aryle substitues par quinuclidine destines au traitement de maladies
AU2001282874A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
MXPA04000779A (es) * 2001-08-24 2004-04-20 Pharmacia & Up John Company 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
MXPA04007936A (es) 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.
MXPA04007083A (es) * 2002-02-20 2004-10-29 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.
FR2861076B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
JP5775819B2 (ja) 2008-10-09 2015-09-09 ハワード ヒューズ メディカル インスティチュート 新規なキメラリガンド開口型イオンチャネルおよびその使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093734A (en) * 1975-11-03 1978-06-06 Boehringer Ingelheim Gmbh Amino-benzoic acid amides
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
US4593034A (en) * 1984-04-06 1986-06-03 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE3689974T2 (de) * 1985-03-14 1994-11-03 Beecham Group Plc Arzneimittel zur Behandlung von Emesis.
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
EP0272052B1 (fr) * 1986-12-16 1992-07-08 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-(1-Azabicyclo[2.2.2]oct-3-yl)benzamides et -thiobenzamides anxiolytiques

Also Published As

Publication number Publication date
EP0306345B1 (fr) 1993-04-14
DE3880240T2 (de) 1993-10-28
ATE88091T1 (de) 1993-04-15
US4877794A (en) 1989-10-31
EP0306345A2 (fr) 1989-03-08
DE3880240D1 (de) 1993-05-19
CA1318595C (fr) 1993-06-01
AU614768B2 (en) 1991-09-12
GB8720805D0 (en) 1987-10-14
AU2183488A (en) 1989-03-09
JPH0269417A (ja) 1990-03-08
ZA886586B (en) 1990-05-30
DK492688A (da) 1989-03-05
DK492688D0 (da) 1988-09-05
EP0306345A3 (en) 1989-06-14
PH25429A (en) 1991-07-01

Similar Documents

Publication Publication Date Title
PH21365A (en) 2-alkoxy-n-(1-azabicyclo(2.2.2) oct -3-yl) benzamides and thiobenzamides
SG120493G (en) N-tert-Butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl) isoquinoline-3-carboxamide and asparaginyl derivatives thereof
EP0262399A3 (en) Cyclic enol derivatives, production and use thereof
IL87662A0 (en) Pharmaceutical compositions containing 2-alkoxy-n-(1-azabi-cyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides
ZA895842B (en) Antischizophrenic-s-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
GB8823605D0 (en) Therapeutic agents
GB8829593D0 (en) Novel compounds
NZ225659A (en) Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives
EP0263506A3 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative
GB8608893D0 (en) D-nor-7-ergoline derivatives
CA2154485A1 (fr) Composition pharmaceutique renfermant la 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone et son emploi pour le traitement des troubles du snc
DE3885978D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
PH20948A (en) 2,5-pyrrolidindione derivatives useful as antiarrhythmic agents